Management of primary T1G3 bladder cancer: immediate cystectomy or bladder preserving approach?
- VernacularTitle:初发T1G3膀胱尿路上皮癌行膀胱全切还是保留膀胱手术?
- Author:
Xiaowen SUN
;
Mingshan YANG
;
Dongbin BI
;
Weiguo LI
;
Haitao LIU
;
Bangmin HAN
;
Sanwei GUO
;
Shujie XIA
- Publication Type:Journal Article
- Keywords:
Bladder neoplasms;
Carcinoma;
Surgical procedures,elective
- From:
Chinese Journal of Urology
2008;29(12):811-814
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the long-term outcomes in patients with newly diagnosed stage T1G3 bladder cancer treated with bladder preserving approach and intravesical instillation or im-mediate cystectomy.Methods of 113 patients with a median age of 64 years (range 27 to 88) diag-nosed with T1G3 bladder cancer from January 1993 to February 2007,81 cases were treated by tran-sureteral resection with additional intravesieal instillation and 32 were treated with immediate cystecto-my.Differences between the 2 groups in 5-year overall survival and tumor specific survival were calcu-lated using the Kaplan-Meier survival function and analyzed by the log rank test.Results of 81 pa-tients treated with organ preserving approach and postoperative intravesical instillation,53 patients developed local recurrence and 21 patients underwent deferred cysteetomy in a median 64 (range 6-140) months follow-up.The overall and tumor specific survival at 5 years was 64.2% (52/81) and 77.8%(63/81),and in those who had deferred cystectomy it was 61.9% (13/21) and 76.2% (16/21),respectively.Of the 32 patients treated with immediate cystectomy,the 5-year overall and tumor specific survival was 59.4%(19/32) and 75.0%(24/32) within a median follow-up of 62(range 4-141)months.There was no statistical difference of the 5-year overall and tumor specific survival be-tween patients treated with bladder preserving approach or immediate cystectomy.Conclusion Blad-der preserving approach and immediate eystectomy might have similar 5-year overall and tumor specific survival for primary T1G3 bladder cancers.